Miles H. Beaman, MBBS; Benjamin J. Luft, MD; Jack S. Remington, MD
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome (AIDS) may result in death even when treated (1). In patients with AIDS, toxoplasmic encephalitis is almost always a reactivation of a pre-existing latent infection (1), most often occurring when the total CD4 count falls below 100 cells/mm-3 (2). Persons at risk can be identified by screening human immunodeficiency virus (HlV)-positive patients for antibody to Toxoplasma gondii. Seroprevalence varies considerably in the general population, ranging from 96% in Western Europe to 10% to 40% in the United States (3). Of those patients with AIDS who are
Learn more about subscription options.
Register Now for a free account.
Beaman MH, Luft BJ, Remington JS. Prophylaxis for Toxoplasmosis in AIDS. Ann Intern Med. 1992;117:163–164. doi: 10.7326/0003-4819-117-2-163
Download citation file:
Published: Ann Intern Med. 1992;117(2):163-164.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only